The chromosomal location of the SCCmec elements containing mecA allows the identification of methicillin-resistant Staphylococcus aureus (MRSA) strains by PCR amplification of a sequence covering the right junction of the SCCmec elements and the adjacent chromosomal region encoding the species-specific ORFX. MRSA strains can be identified specifically using one forward primer, with only one or two mismatches, targeting the SCCmec elements of different types, and one reverse primer targeting the orfX region.
The emergence and spread of methicillin-resistant Staphylococcus aureus (MRSA), both as a nosocomial pathogen and, more recently, in the community, are matters of concern worldwide. S. aureus acquires methicillin resistance by insertion into the chromosome of a mobile genetic element, designated staphylococcal cassette chromosome (SCCmec), carrying the mecA gene. This gene encodes an additional penicillin-binding protein, PBP2a, which is not inhibited by existing b-lactam antibiotics [1] . At least five different types of SCCmec elements have been described, characterised by different classes of site-specific recombinase genes (ccr complex), the mec gene complex, insertion sequences and, in two cases, transposon Tn554 [2, 3] . SCCmec elements are flanked by incomplete inverted repeats, and are integrated at a specific site (attBSCC) in the S. aureus chromosome, which is located at the 3¢-end of orfX [4] .
PCR-based detection of MRSA has mostly been based on individual amplification of an S. aureusspecific gene and mecA, as described recently for a duplex real-time PCR with mecA-and nuc-specific primers [5] . This approach is not immediately applicable to the detection of MRSA from nonsterile clinical specimens, which often contain both S. aureus and methicillin-resistant coagulasenegative staphylococci (CNS), thereby potentially yielding false-positive results. An alternative approach involves the selective immunomagnetic enrichment of S. aureus and a subsequent multiplex PCR [6] . A further possibility is the amplification of a sequence covering both SCCmec and the S. aureus-specific orfX region. Because of the sequence differences at the right extremity of the SCCmec elements, the assay described by Huletsky et al. [7] uses five different primers to target SCCmec types I-V and one primer for orfX. However, the emergence of new SCCmec types, especially among community-acquired MRSA [8] , may require the use of additional primers.
Following comparison of sequences at the right junction of SCCmec and orfX, a 16-bp region of relatively high homology was found, with only 1 or 2 bp differences between the SCCmec elements of types I-V ( Table 1 ). The present study describes the use of a PCR assay, with this sequence as the forward primer and a highly conserved sequence in orfX as the reverse primer, to identify MRSA containing different types of SCCmec elements. The primer sequences used in this assay were: rjmec (forward), 5¢-TAT-GATATGCTTCTCC (positions 57641-57656, accession number D86934); and ORFX1r (reverse), 5¢-AACGTTTAGGCCCATACACCA (58042-58022, D86934).
The S. aureus reference strain used was NCTC 8325. Reference strains of MRSA containing SCCmec elements of types I-V were NCTC 10442 (I), N315 (II), 85 ⁄ 2082 (III), 1155 ⁄ 93 (IV) and WIS (V). The reference strain for S. aureus containing SCCmec cap1 was strain M. Reference strains of CNS were: S. auricularis, ATCC33753; S. capitis, CCM2734; S. capitis subsp. ureolyticus, ATCC49326; S. caprae, CCM3573; S. carnosus, The clinical isolates of methicillin-susceptible S. aureus (MSSA) and MRSA investigated were sent from representative regions in Germany to the authors' laboratory, which is the national reference centre for typing of staphylococci. The MRSA isolates were characterised by multilocus sequence typing according to Enright et al. [9] and by SCCmec typing using PCR according to Okuma et al. [10] . Subtypes of type IV (a-d) were determined as described by Huletzky et al. [7] . The clinical isolates of different species of CNS (n = 80) originated from blood cultures of patients showing symptoms of intravenous catheterrelated septicaemia.
Total cellular DNA was prepared from staphylococci grown overnight on blood agar plates and suspended in NaCl 0.9% w ⁄ v to a density corresponding to a 0. With the use of primers rjmec and ORFX1r, PCR products of c. 400 bp were obtained from the reference strains containing SCCmec elements of types I, II, III, IV and V, and from all clinical MRSA isolates investigated. A representative set of PCR products is shown in Fig. 1 . The results Table 2 . MRSA strains of MLST types ST05, ST22, ST45, ST228, ST254 and ST247 are the major epidemic clones in Central Europe. MRSA strains of types ST01, 30 and 80 are community-acquired MRSA strains that have emerged recently [8] . The PCR approach also allowed the detection of MRSA strains with as yet unidentified SCCmec elements ( Table 2 ) that yielded negative results with PCRs targeting the known ccr complexes [3, 7] and sequences of types IVa, IVb, IVc, IVd and V. The PCR produced no amplification product for 100 clinical MSSA isolates of different origins with different SmaI macrorestriction patterns. The PCR was also negative with the reference strains of CNS, with the exception of the S. delphinii reference strain, which gave a weak positive reaction (Fig. 1) ; however, this PCR product did not hybridise with a mecA-specific probe (data not shown). Furthermore, the PCR was negative with 130 clinical isolates of CNS, 90 of which contained mecA.
Detection systems for MRSA that are based on reverse blotting and use an MRSA-specific capture probe require smaller amplimers. This can be achieved by using primer ORFX2r (5¢-AT-GACATTCCCACATCAAATC; positions 38942-38922; accession number AB033767), which yields an 89-bp amplimer.
The advantage of the PCR test described in this study is the use of only one primer set for the detection of MRSA belonging to a variety of different SCCmec types. However, the specificity of this method may be an issue for strains of S. aureus containing a staphylococcal cassette chromosome lacking mecA, as described for SCCcap1. This element harbours the cap1 genes responsible for production of a type 1 capsular polysaccharide [11] . As expected, the PCR was positive for S. aureus strain M harbouring SCCcap1 (Fig. 1) . However, S. aureus strains of capsular type 1 are rare, with the most frequent being types 5 and 8 [12] . None of the 100 MSSA isolates of different origins and with different SmaI macrorestriction patterns were PCR-positive, yielding the c. 400 bp product. Other SCC elements have been described for CNS [13] . However, this will not interfere with the PCR approach described here, since these species differ from S. aureus in the chromosomal sequences next to the 3¢ junction of the cassette.
Rapid detection of MRSA directly from clinical specimens and nasal swabs is important for timely and appropriate treatment and infection control. In particular, screening of patients for MRSA upon hospital admission must produce quick results in order to be effective [14] . The possible use of the PCR assay described here for the direct detection of MRSA in clinical samples is currently being investigated. 
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